RDYY vs. BIB

Last updated Jun 4, 2026

RDYY (YieldMax RDDT Option Income Strategy ETF) and BIB (ProShares Ultra Nasdaq Biotechnology) are both exchange-traded funds - RDYY is a Derivative Income fund actively managed by YieldMax, while BIB is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (200%). RDYY is actively managed, while BIB is passively managed. At a 0.17 correlation, their price movements are largely independent. RDYY charges 0.99%/yr vs 0.95%/yr for BIB.

Performance

RDYY vs. BIB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in YieldMax RDDT Option Income Strategy ETF (RDYY) and ProShares Ultra Nasdaq Biotechnology (BIB). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RDYY achieves a -22.78% return, which is significantly lower than BIB's -0.51% return.

RDYY

• 1D: 0.78%
• 1M: 2.65%
• YTD: -22.78%
• 6M: -20.14%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

BIB

• 1D: 3.49%
• 1M: -3.84%
• YTD: -0.51%
• 6M: -3.00%
• 1Y: 76.61%
• 3Y*: 14.49%
• 5Y*: -1.02%
• 10Y*: 5.68%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RDYY vs. BIB - Yearly Performance Comparison

	2026 (YTD)	2025
RDYY YieldMax RDDT Option Income Strategy ETF	-22.78%	-6.52%
BIB ProShares Ultra Nasdaq Biotechnology	-0.51%	36.69%

Correlation

The correlation between RDYY and BIB is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Sep 10, 2025	0.17

Return for Risk

RDYY vs. BIB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIB

BIB Risk / Return Rank: 63
BIB Sharpe Ratio Rank: 57
BIB Sortino Ratio Rank: 53
BIB Omega Ratio Rank: 48
BIB Calmar Ratio Rank: 84
BIB Martin Ratio Rank: 76

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RDYY vs. BIB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for YieldMax RDDT Option Income Strategy ETF (RDYY) and ProShares Ultra Nasdaq Biotechnology (BIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	RDYY	BIB	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.95	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.02	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.12	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.67	0.34	-1.00

Drawdowns

RDYY vs. BIB - Drawdown Comparison

The maximum RDYY drawdown since its inception was -51.16%, smaller than the maximum BIB drawdown of -67.24%. Use the drawdown chart below to compare losses from any high point for RDYY and BIB.

Drawdown Indicators

	RDYY	BIB	Difference
Max Drawdown Largest peak-to-trough decline	-51.16%	-67.24%	+16.08%
Max Drawdown (1Y) Largest decline over 1 year	—	-16.92%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-45.30%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-65.86%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-66.20%	—
Current Drawdown Current decline from peak	-34.14%	-26.85%	-7.29%
Average Drawdown Average peak-to-trough decline	-28.62%	-32.74%	+4.12%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	5.30%	—

Volatility

Volatility by Period

	RDYY	BIB	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	13.91%	—
Volatility (6M) Calculated over the trailing 6-month period	—	30.57%	—
Volatility (1Y) Calculated over the trailing 1-year period	54.12%	39.59%	+14.53%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	54.12%	43.56%	+10.56%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	54.12%	46.50%	+7.62%

RDYY vs. BIB - Expense Ratio Comparison

RDYY has a 0.99% expense ratio, which is higher than BIB's 0.95% expense ratio.

Dividends

RDYY vs. BIB - Dividend Comparison

RDYY's dividend yield for the trailing twelve months is around 83.18%, more than BIB's 0.62% yield.

Position	TTM	2025	2024	2023	2022
BIB ProShares Ultra Nasdaq Biotechnology	0.62%	0.77%	1.69%	0.07%	0.03%
RDYY YieldMax RDDT Option Income Strategy ETF	83.18%	25.20%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both RDYY and BIB in my portfolio?

RDYY and BIB have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, RDYY or BIB?

On fees, BIB is cheaper at 0.95% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, RDYY or BIB?

BIB is cheaper with a 0.95% expense ratio, compared with 0.99% for RDYY.

Which ETF pays a higher dividend yield, RDYY or BIB?

RDYY has the higher dividend yield at 83.18%, compared with 0.62% for BIB.

What is the main difference between RDYY and BIB?

RDYY is categorized as Derivative Income, while BIB is Leveraged Equities. They also come from different issuers: YieldMax and ProShares. Their fees differ too: 0.99% for RDYY and 0.95% for BIB.